Skip to content

Efficacy and safety of neuromuscular electrical stimulation for prevention-improvement of stress injuries in bedridden stroke patients

Efficacy and safety of neuromuscular electrical stimulation for prevention-improvement of stress injuries in bedridden stroke patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081502
Enrollment
Unknown
Registered
2024-03-04
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pressure injury

Interventions

Routine nursing group:Routine care measures
NMES group:Routine nursing measures and NMES applied to the sacrococcygeal region

Sponsors

Yuebei People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Patients aged 18-75 who have been diagnosed with stroke through CT or MRI. ?The patient or guardian agrees to sign the informed consent for the trial. ? The onset time was within one month and there was no sacrococcygeal pressure injury. ?The patient lacks the ability to autonomously roll, stand, and transfer movements, and requires assistance to complete the above actions.

Exclusion criteria

Exclusion criteria: ? Pregnancy, pacemaker or defibrillator implantation; ? Preexisting neuromuscular diseases (Duchenne's disease, myasthenia gravis, Guillain Barre syndrome), brain death, spinal cord injury, BMI greater than or equal to 35 km/m2, rhabdomyolysis, skin injury at electrode application site, or medical contraindications.

Design outcomes

Primary

MeasureTime frame
Incidence of pressure injuries;Waterlow pressure sore risk assessment scale;Barden Assessment Form;

Countries

China

Contacts

Public ContactWeili Zhu

Yuebei People's Hospital

416510988@qq.com+86 189 2259 9170

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026